Glaxo Says Its COVID-19 Antibody Treatment Effective Against Omicron

Contact Your Elected Officials
The Epoch Times Header

British drugmaker GlaxoSmithKline said early-stage lab data shows its COVID-19 monoclonal antibody treatment, jointly developed with U.S. partner Vir Biotechnology, is effective against all mutations of the new Omicron strain.

Glaxo said in a Dec. 7 statement that new preclinical findings generated from in vitro testing of the drug, called sotrovimab, show that the treatment is effective against all 37 identified mutations to date in Omicron’s spike protein.

“These pre-clinical data demonstrate the potential for our monoclonal antibody to be effective against the latest variant, Omicron, plus all other variants of concern defined to date” by the World Health Organization (WHO), said Dr. Hal Barron, Chief Scientific Officer and President of Research and Development, at GSK.

The data, which has not yet been peer reviewed, builds on earlier preclinical findings released last week, which showed sotrovimab was effective against key Omicron mutations.

“Sotrovimab is the first monoclonal antibody to report preclinical data demonstrating activity against all tested SARS-CoV-2 variants of concern and interest to date, including Omicron, as well as the still prevalent and highly contagious Delta variant,” George Scangos, CEO of Vir Biotechnology, said in a statement.

SARS-CoV-2 is the scientific name for the CCP (Chinese Communist Party) virus, the pathogen that causes the disease COVID-19.

While much remains unknown about Omicron, which has been detected in dozens of countries including the United States, it appears to spread more quickly than other variants, though early signs from a study in South Africa suggest it may cause milder illness.

Sotrovimab has been approved for emergency use by the U.S. Food and Drug Administration (FDA) and recently gained approval for use in the United Kingdom.

The FDA authorized the antibody treatment for use in people who have mild to moderate COVID-19 and who are at high risk for progression to severe disease.

By Tom Ozimek

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Five Reasons Why The Latest Czech Elections Were So Important

Populist-nationalist politician Andrej Babis is poised to return to the premiership after his party's victory. Here are 5 reasons why this is so important.

Bad Bunny is the NFL’s Latest Insult

After years of advocating social justice causes, the NFL chose left wing, gender fluid rapper Bad Bunny to headline the next Super Bowl. Does the NFL want conservatives fans?

Scheduling collides with legacy

The ACC’s footprint now sprawls from Boston and Miami to Salt Lake City and the San Francisco Bay, defying both geography and its own name.

The Paradoxical Patriot: The political odyssey of Frank S. Meyer

In his book, Daniel J. Flynn examines the ideological evolution of one of conservatism’s most paradoxical and overlooked architects, Frank S. Meyer. 

This Is America: Target™ Reparations

“This Is America” explores the cultural undercurrents pulling Western...

Trump Open to ‘Right Deal’ on Obamacare Subsidies Amid Shutdown Standoff

Trump is open to making a deal on Affordable Care Act subsidies, a key demand of Democrats in standoff over temporary funding of the federal govt.

CDC Endorses Standalone Chickenpox Vaccination for Younger Children

CDC stopped recommending a combination vaccine that contains a varicella component, advising a standalone shot against the disease.

CDC Says COVID-19 Vaccination Now Up to Each Individual

CDC no longer broadly recommends COVID-19 vaccination, each person should look at a range of factors, and consult their doctor, before receiving a shot.

Illinois Sues Trump Admin to Halt National Guard Deployment to Chicago

Illinois filed a lawsuit against the Trump admin on Oct. 6 in a bid to halt the federal govt from deploying National Guard troops to Chicago.

Trump: All Medium, Heavy Duty Trucks Entering US Will See 25 Percent Tariff on Nov. 1

President Trump announced on Monday that all medium and heavy-duty trucks entering the United States will see a 25 percent tariff starting on Nov. 1.

Treasury Names Social Security Commissioner as CEO of IRS

Treasury Sec. Scott Bessent announced that Frank Bisignano, the head of the Social Security Administration (SSA), will also serve as CEO of the IRS.

Agencies Terminated, Descoped 94 Wasteful Contracts With $8.5 Billion Ceiling Value, Says DOGE

Various federal government agencies have terminated and descoped 94 wasteful contracts over the past five days, DOGE said in an Oct. 4 post on X.

Department of Energy Cancels $7.5 Billion in Project Funding

The Dept of Energy (DOE) said on Oct. 2 that it had terminated 321 federal grants funding 223 projects, amounting to about $7.56 billion in cuts.
spot_img

Related Articles

Popular Categories

MAGA Business Central